Skip to Content

Pharmaceutics, Volume 18, Issue 9

2026 September - 151 articles

Cover Story: CNS drug delivery faces barriers beyond BBB, and increasing drug exposure in the brain cannot ensure effective drug accumulation at subcellular action sites. This review firstly examines the dysfunctions and therapeutic targets in mitochondrial, lysosomal, nuclei, and endoplasmic reticulum in the diseases of neuroinflammation and brain tumors, and it emphasizes that organelle-targeted therapy rationales differ by disease. Then, it highlights organelle-targeted drug delivery strategies and carrier platforms, including liposomes, polymeric nanoparticles, biomimetic membrane-based carriers, exosome-like carriers, and focused ultrasound-assisted systems. Moreover, it summarizes delivery techniques, formulation characterization, clinical trials, translational bottlenecks, and future prospects. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (151)

  • Article
  • Open Access
480 Views
23 Pages

Background/Objectives: Solid self-nanoemulsifying drug delivery systems (SNEDDS) prepared by adsorption onto porous carriers are widely used to improve the oral delivery of poorly water-soluble drugs. However, this approach is limited by increased do...

(This article belongs to the Section Drug Delivery and Controlled Release)
  • Article
  • Open Access
490 Views
17 Pages

Population Pharmacokinetics and Extrapolation of NP-011 from Animal to Humans: A Novel Therapeutic Candidate Protein for Metabolic Dysfunction-Associated Steatohepatitis

  • Hyunjung Lee,
  • Quyen Thi Tran,
  • Bui Thi Tham,
  • Min-Kyoung Kim and ,
  • Hwi-Yeol Yun,
  • Jung-Woo Chae,
  • Jung-Hyuck Park and
  • Soyoung Lee
  • + 3 authors+ 0 author

Background/Objective: Metabolic dysfunction-associated steatohepatitis (MASH), an advanced stage of metabolic dysfunction-associated steatotic liver disease (MASLD), is characterized by progressive liver fibrosis and represents an important therapeut...

(This article belongs to the Special Issue Mechanism-Based Pharmacokinetic and Pharmacodynamic Modeling, 2nd Edition)
  • Article
  • Open Access
549 Views
21 Pages

Angelica dahurica Exosome-like Nanovesicles Delivered by Ultrasonic Nebulization Alleviate Allergic Rhinitis and Modulate NF-κB Signaling

  • Anqi Zhou,
  • Xiao Li,
  • Lin Zhao,
  • Song Zhang and ,
  • Xiaowei Li,
  • Qiulin Yue,
  • Xin Sun,
  • Kai Zheng and
  • Le Su
  • + 4 authors+ 0 author

Background: Current treatments for allergic rhinitis (AR) are associated with side effects and do not provide a definitive cure. Angelica dahurica has recognized anti-inflammatory activity; however, the therapeutic potential of Angelica dahurica-deri...

(This article belongs to the Section Nanomedicine and Nanotechnology)
  • Review
  • Open Access
611 Views
29 Pages

Mechanism-Driven Design of Metal–Phenolic Networks: From Precision Assembly to Multidimensional Synergistic Therapy for Brain Diseases

  • Mengyue Ni,
  • Bo Hu,
  • Di Zhu,
  • Boya Li and ,
  • Yijiang Jia,
  • Yu Lu and
  • Yuji Wang
  • + 2 authors+ 0 author

Background: Brain disorders, such as glioblastoma, Alzheimer’s disease and ischemic stroke, represent formidable challenges due to the highly restrictive blood–brain barrier (BBB) and the complex pathophysiological microenvironment, which...

(This article belongs to the Section Drug Delivery and Controlled Release)
  • Review
  • Open Access
1 Citations
756 Views
55 Pages

Translational Pharmaceutical Perspectives on Quinones as Antioxidant and Antidiabetic Agents in Diabetes and Its Complications

  • Krishnendu Adhikary,
  • Thirtsha Shohani Godwin,
  • Adsaya Karunanithi,
  • Riya Sarkar and ,
  • Md. Abubakar,
  • Sayoni Nag,
  • Saurav Barman,
  • Nilanjana Datta and
  • Rajkumar Maiti
  • + 4 authors+ 0 author

Background: Diabetes mellitus (DM) is an extremely complex metabolic disorder, with many factors contributing to persistent hyperglycaemia, redox dysregulation, and micro- and macrovascular damage over time. There is growing evidence that oxidative s...

(This article belongs to the Section Biopharmaceutics)
  • Review
  • Open Access
789 Views
32 Pages

Narrow Therapeutic Index Drugs: Regulatory Frameworks, Bioequivalence, and Model-Informed Precision Dosing

  • Mengmeng Liu,
  • Zhe Wang,
  • Yongbo Chen,
  • Yuqi Jia and ,
  • Lei Xu,
  • Haojie Xu,
  • Jueyu Li and
  • Libo Zhao
  • + 3 authors+ 0 author

Background/Objectives: Narrow therapeutic index (NTI) drugs are characterized by a small margin between effective and toxic exposure. This review aimed to summarize international definitions and regulatory frameworks for NTI drugs, compare bioequival...

(This article belongs to the Special Issue Therapeutic Drug Monitoring as a Useful Tool in Therapy Improvement, 3rd Edition)
  • Review
  • Open Access
670 Views
23 Pages

Small Nucleic Acid Therapeutics for Ocular Diseases: Progress, Challenges, and Future Perspectives

  • Qi Guo,
  • Lushu Chen,
  • Ziyan Wu,
  • Qiuyang Zhang and ,
  • Jinsong Xue and
  • Huiying Zhang
  • + 1 author+ 0 author

Ocular diseases remain a major global health challenge with substantial unmet therapeutic needs. Small nucleic acid therapeutics offer a precise strategy to regulate disease-related mRNAs or noncoding RNAs through base pairing, thereby modulating pro...

(This article belongs to the Section Gene and Cell Therapy)
  • Article
  • Open Access
501 Views
25 Pages

Design and Optimization of Self-Nanoemulsifying Drug Delivery Systems to Enhance the Anti-Inflammatory Efficacy of Derris scandens (Roxb.) Benth. Extract

  • Nattakanwadee Khumpirapang,
  • Kantapich Srikham,
  • Thapakorn Somboon,
  • Krit Suknuntha and ,
  • Daniela Gruľová,
  • Neti Waranuch,
  • Kornkanok Ingkaninan and
  • Siriporn Okonogi
  • + 3 authors+ 0 author

Background/Objectives: Derris scandens (Roxb.) Benth. stem extract (DSE) is used in Thailand for musculoskeletal pain, but its bioactive, lupalbigenin, has limited aqueous solubility. This study aimed to develop a DSE-loaded self-nanoemulsifying...

(This article belongs to the Section Drug Delivery and Controlled Release)
  • Article
  • Open Access
443 Views
18 Pages

Background/objectives: Febuxostat (FBXT), a xanthine oxidase (XO) inhibitor, is a urate-lowering drug commonly used to treat gout. XO is also a promising therapeutic target for inflammatory bowel disease (IBD). This study aimed to improve the efficac...

(This article belongs to the Section Drug Delivery and Controlled Release)
  • Article
  • Open Access
788 Views
22 Pages

3D-Printing of Magnetoactive Gelatin–Alginate Scaffolds

  • Sofía Municoy,
  • Exequiel Giorgi,
  • María Edith Farías,
  • Romina B. Currá and ,
  • Hina N. Chaudhari,
  • Rajshree B. Jotania,
  • Robert C. Pullar,
  • Mauricio De Marzi and
  • Martín F. Desimone
  • + 4 authors+ 0 author

Background/Objectives: Magnetically responsive biomaterials have emerged as promising platforms for tissue engineering as they allow remote stimulation of cells and improved control over tissue regeneration. Although gelatin–alginate hydrogels...

(This article belongs to the Special Issue Magnetic Nanoparticles in Regenerative Medicine and Tissue Engineering)
  • Article
  • Open Access
614 Views
19 Pages

Innovative 3D-Printed Devices with Modified Prednisolone Release for Colon-Targeted Drug Delivery Systems

  • Dareena Jaiseri,
  • Supusson Pengnam,
  • Praneet Opanasopit,
  • Theerada Taesotikul and ,
  • Boonnada Pamornpathomkul,
  • Chaiyakarn Pornpitchanarong,
  • Phuvamin Suriyaamporn,
  • Theerasak Rojanarata,
  • Teeratas Kansom and
  • Thapakorn Charoenying
  • + 5 authors+ 0 author

Background: Prednisolone conventional tablet is a drug commonly used to treat inflammatory bowel disease (IBD). However, the long-term use of high doses of prednisolone can lead to gastric irritation, risk of infection, and other systemic complicatio...

(This article belongs to the Special Issue 3D Printing and Personalized Medicine: Advancing Drug Delivery Systems)
  • Article
  • Open Access
573 Views
18 Pages

Honokiol-Loaded β-D-Glucan/Chitosan Nanoparticles with Antibacterial and Anti-Inflammatory Activities for Promoting MRSA-Infected Wound Healing

  • Shouli Yi,
  • Ming Guan,
  • Hongjuan Zhang,
  • Ping Qiu and ,
  • Shengyi Wang and
  • Tingjun Hu
  • + 1 author+ 0 author

Background: Methicillin-resistant Staphylococcus aureus (MRSA) wound infections are a major clinical concern due to their high prevalence and the growing risk of antimicrobial resistance. Therefore, it is imperative to develop safe and effective ther...

(This article belongs to the Section Nanomedicine and Nanotechnology)
  • Article
  • Open Access
538 Views
15 Pages

Background/Objectives: Reformulating oral drugs for vaginal delivery is a current therapeutic strategy for genitourinary tract infections. Bioadhesive delivery systems, by interacting with the mucosal epithelium, improve drug deposition at the applic...

(This article belongs to the Special Issue Advances in the Preparation and Technology of Pharmaceutical Solid Dosage Forms, 2nd Edition)
  • Review
  • Open Access
642 Views
44 Pages

Advanced Ophthalmic Drug Delivery in Homocystinuria Type CblC: A Translational Review of Ophthalmic Pathologies and Therapeutic Opportunities

  • Selene Cuello-Rodríguez,
  • Martina Sanna,
  • Imelda Lecoeuche,
  • Bruno Sarmento and ,
  • Francisco J. Otero-Espinar and
  • Victoria Díaz-Tomé
  • + 1 author+ 0 author

Homocystinuria type CblC is a congenital error in cobalamin metabolism characterized by increased homocysteine and methylmalonic acid levels, together with a reduced methionine availability. This metabolic imbalance leads to multisystemic pathologies...

(This article belongs to the Special Issue Ocular Drug Delivery Systems and Formulations)
  • Review
  • Open Access
668 Views
28 Pages

Nanoformulations for Ocular Drug Delivery in Glaucoma: From Metal-Based Nanoparticles to Advanced Nanocarriers

  • Ionut Iulian Lungu,
  • Liviu Stafie,
  • Alina Stefanache,
  • David-Constantin Stefan and ,
  • Andreea Lungu,
  • Georgiana-Elena Sarbu,
  • Liliana Savin,
  • Andreea Guraliuc,
  • Francesca Cristiana Dohotariu and
  • Nicoleta Anton
  • + 5 authors+ 0 author

Glaucoma is a chronic and progressive optic neuropathy in which sustained intraocular pressure (IOP) reduction remains the main therapeutic objective, while increasing attention is being directed toward neuroprotective strategies and improved ocular...

(This article belongs to the Special Issue Ocular Drug Delivery Systems and Formulations)
  • Article
  • Open Access
629 Views
24 Pages

Development and Characterization of a Hydrogel Incorporating Protamine–Hyaluronic Acid Nanoparticles Co-Loaded with Disulfiram and Coumarin for Diabetic Wound Healing

  • Zainab Lafi,
  • Mohammad I. A. Ahmad,
  • Shreen Deeb Nusair,
  • Razan Madi and ,
  • Alaa Al-Sanabrah,
  • Somaya Ahmad,
  • Qout Qtashat,
  • Maisrh Ali Alrubaye and
  • Sara Yousef Asha
  • + 4 authors+ 0 author

Background: Diabetes-associated wound healing is frequently impaired due to persistent hyperglycemia, which causes vascular dysfunction and neuropathy, thereby delaying tissue repair. Objectives: In this study, hyaluronic acid and protamine nanoparti...

(This article belongs to the Topic Advanced Biomaterials for Wound Healing: From Design to Application)
  • Article
  • Open Access
1 Citations
633 Views
19 Pages

EGFR-Targeted Nanoparticle Delivery of Osimertinib for Triple-Negative and Metastatic Breast Cancer Therapy

  • Iman M. Alfagih,
  • Maryam Alfagih,
  • Alanood Almurshedi,
  • Basmah Aldosari and ,
  • Bushra Alquadeib,
  • Baraa Hajjar,
  • Shahad Almogheerah and
  • Rund Alzahrani
  • + 3 authors+ 0 author

Background/objective: Osimertinib, an EGFR-targeted agent approved for metastatic NSCLC, shows promise for triple-negative breast cancer due to EGFR overexpression in aggressive tumors. However, oral administration limits tumor delivery and causes sy...

(This article belongs to the Special Issue Kinase Inhibitors: Innovative Delivery Strategies and Anticancer Potential)
  • Article
  • Open Access
678 Views
18 Pages

Long-Term Survival Heterogeneity Across PD-L1-Defined Subgroups in Pembrolizumab-Treated Non-Small-Cell Lung Cancer: A Model-Based Analysis

  • Heungjo Kim,
  • Sungjae Lee,
  • Hongjae Lee,
  • Ji Woo Lim and ,
  • Tahir Sher,
  • Chanwoo Kim,
  • Junjeong Choi,
  • Sun Min Lim and
  • Min Jung Chang
  • + 4 authors+ 0 author

Background/Objectives: Immune checkpoint inhibitors have substantially improved survival outcomes in non-small-cell lung cancer (NSCLC). However, survival heterogeneity across PD-L1-defined and other clinically relevant patient subgroups remains inco...

(This article belongs to the Special Issue Emerging Strategies in Drug Development and Clinical Care in the Era of Personalized and Precision Medicine, 3rd Edition)
  • Review
  • Open Access
2 Citations
608 Views
32 Pages

Beyond Anti-VEGF: Toward Integrated Precision Care in Diabetic Retinal Disease

  • Jesus H. Gonzalez-Cortes,
  • Jesus E. Gonzalez-Cantu,
  • Alper Bilgic,
  • Francesc March de Ribot and ,
  • Aditya Sudhalkar,
  • Laurent Kodjikian,
  • David Pelayes,
  • Thibaud Mathis and
  • Jesus Mohamed-Hamsho
  • + 4 authors+ 0 author

Diabetic retinal disease (DRD) remains one of the leading causes of preventable vision loss worldwide and continues to represent a major global public health challenge despite remarkable therapeutic advances over the past two decades. Intravitreal an...

(This article belongs to the Section Clinical Pharmaceutics)
  • Article
  • Open Access
572 Views
15 Pages

Background/Objectives: Peripheral neuropathy affects up to 50% of people living with HIV (PLWH). Currently, no small translational rodent model accurately replicates the peripheral neuropathy observed in PLWH. The primary objectives of this study are...

(This article belongs to the Section Biopharmaceutics)
  • Article
  • Open Access
579 Views
16 Pages

Developing a Method to Quantify Swelling Force Generated by the Osmotic Pump Tablet Push Layer

  • True L. Rogers,
  • Stephanie Robart,
  • Thomas Watson,
  • Rhea Wang and ,
  • Harold Bernthal and
  • Vahid Ahmadi
  • + 1 author+ 0 author

Background/Objectives: A push–pull osmotic pump (PPOP) tablet is a controlled-release delivery system consisting of a bilayer tablet (push layer/pull (drug) layer), coated within a selectively permeable barrier membrane, and containing a laser-...

(This article belongs to the Special Issue Innovative Oral and Topical Drug Delivery Systems: Formulation Design, Optimization and Quality Control)
  • Article
  • Open Access
600 Views
21 Pages

Calcifediol Treatment Improves Skin Wound Healing in Vitamin D Deficiency Obese Rats

  • Bárbara Torrecillas-Baena,
  • Victoria Pulido-Escribano,
  • Marta Camacho-Cardenosa,
  • María Dolores Carmona-Luque and ,
  • Laura De los Santos Castillo-Peinado,
  • Feliciano Priego-Capote,
  • José Manuel Quesada-Gómez,
  • Gabriel Dorado,
  • María Ángeles Gálvez-Moreno and
  • Antonio Casado-Díaz
  • + 5 authors+ 0 author

Background/Objectives: Obesity is a major public health problem and a risk factor for numerous diseases. Furthermore, the high prevalence of 25-hydroxyvitamin D (25(OH)D) deficiency in obese individuals promotes a state of persistent inflammation and...

(This article belongs to the Section Biopharmaceutics)
  • Article
  • Open Access
530 Views
14 Pages

Non-Systemic Oral Cellulose-Based Superabsorbent Hydrogels for Weight Management: Potential Drug-Device Interactions Estimated by a Simplified In Vitro Assay

  • Eliana Panteca,
  • Ivo Surano,
  • Christian Demitri,
  • Yishai Zohar and ,
  • Marta Madaghiele and
  • Alessandro Sannino
  • + 1 author+ 0 author

Background/Objectives: A technological platform of non-systemic oral cellulose-based superabsorbent hydrogels (CB-SAHs) has been recently developed as novel therapeutics for treating obesity. Further clinical advancement of CB-SAH candidates from thi...

(This article belongs to the Section Pharmaceutical Technology, Manufacturing and Devices)
  • Article
  • Open Access
563 Views
18 Pages

Disulfiram’s Anti-Inflammatory and Antibacterial Effects in Fixed-Dose Combination Therapy for Scabies

  • Carmen Salavastru,
  • Angela Hernández-Martín,
  • Sanja Bulut,
  • Laura Fernàndez Fajardo and ,
  • Aymée Robainas Barcia and
  • Maria Lajarin-Reinares
  • + 1 author+ 0 author

Background/Objectives: Scabies is a highly contagious parasitic skin infestation in which mite infestation, epidermal barrier disruption, secondary bacterial infection, and local inflammation collectively contribute to disease burden. This study inve...

(This article belongs to the Section Drug Targeting and Design)
  • Review
  • Open Access
1 Citations
1,124 Views
26 Pages

Oral absorption remains challenging for peptides, proteins, and other drug substances with limited stability or permeability. Sodium N-(8-[2-hydroxybenzoyl]amino)caprylate (SNAC), also known as salcaprozate sodium, is an oral permeation enhancer used...

(This article belongs to the Section Biopharmaceutics)
  • Article
  • Open Access
1 Citations
555 Views
26 Pages

Morin-Loaded PLGA-Chitosan Nanoparticles Attenuate PTZ-Induced Seizure-Related Behavioral, Biochemical, and Transcriptional Changes in Male Rats

  • Ashraf Kakoo,
  • Azad Hasan Kheder,
  • Ali A. Mohammedsaeed,
  • Trefa Salih Mohamad and ,
  • Mohammed Awat Ali,
  • Mohammad B. Ghayour,
  • Arash Abdolmaleki,
  • Dlzar B. Rahman,
  • Shang Ziyad Abdulqadir and
  • Shukur Wasman Smail
  • + 7 authors+ 2 authors

Aims: Morin is a flavonoid with potential neuroprotective and anti-inflammatory properties. This study evaluated the anticonvulsant and anxiolytic effects of morin-loaded PLGA-chitosan nanoparticles (Morin-PLGA-CS NPs) in male Wistar rats. Methods: M...

(This article belongs to the Section Nanomedicine and Nanotechnology)
  • Review
  • Open Access
680 Views
30 Pages

Chronic Spontaneous Urticaria in the Era of Targeted Therapy: From Pathogenic Mechanisms to Precision Medicine

  • Klara Andrzejczak,
  • Wiktor Witkowski,
  • Joanna Górka-Dynysiewicz,
  • Robert Pawłowicz and
  • Agnieszka Kopeć

Chronic spontaneous urticaria (CSU) is a common and heterogeneous inflammatory skin disease characterized by recurrent wheals and/or angioedema for more than six weeks. Despite treatment with second-generation antihistamines, many patients remain sym...

(This article belongs to the Special Issue Therapeutic Advances in Chronic Diseases: Innovation and Drug Repurposing)
  • Review
  • Open Access
701 Views
50 Pages

Do We Still Need Chemistry for Water-Soluble Prodrugs? What Biocatalysis Already Does, and What It Does Not

  • Federico Zappaterra,
  • Domenico Meola,
  • Francesco Presini,
  • Lindomar Alberto Lerin and
  • Pier Paolo Giovannini

Poor aqueous solubility limits roughly 40% of marketed oral drugs and up to ~90% of development candidates. One established remedy is the prodrug strategy: the covalent attachment of a bioreversible promoiety that regenerates the parent drug in vivo....

(This article belongs to the Special Issue Prodrug Strategies for Enhancing Drug Stability and Pharmacokinetics)
  • Article
  • Open Access
436 Views
35 Pages

Mucoadhesive Nanoemulsions for Nose-to-Brain Delivery of Dimethyl Fumarate: Development, Characterization and Proof-of-Concept In Vivo Evaluation

  • Eleonora Sofia Cama,
  • Giada Botti,
  • Sara Perteghella,
  • Laura Catenacci and ,
  • Fahad Khan Tareen,
  • Sarah Beggiato,
  • Maria Cristina Bonferoni,
  • Luca Ferraro,
  • Milena Sorrenti and
  • Alessandro Dalpiaz
  • + 5 authors+ 0 author

Background: Dimethyl fumarate (DMF) is an approved therapeutic agent for the treatment of multiple sclerosis, known for its anti-inflammatory and neuroprotective properties. However, its oral administration is often accompanied by gastrointestinal si...

(This article belongs to the Special Issue Advances in Nanotechnology-Based Drug Delivery Systems, 2nd Edition)
  • Review
  • Open Access
719 Views
36 Pages

Background: Pathological activation of oxidative metabolism is a universal catalyst for liver parenchyma destruction. While physiological pools of reactive oxygen and nitrogen species (ROS/RNS) regulate hepatic regeneration and cellular respiration,...

(This article belongs to the Section Drug Targeting and Design)
  • Article
  • Open Access
758 Views
19 Pages

Background/Objectives: Canine superficial pyoderma is one of the most common dermatological diseases in dogs and is increasingly complicated by antimicrobial resistance. This study aimed to develop ethyl lauroyl arginate-integrated lipid-based nanopa...

(This article belongs to the Section Nanomedicine and Nanotechnology)
  • Article
  • Open Access
560 Views
23 Pages

Background/Objectives: Current treatments for tuberculosis (TB) are complex and associated with severe side effects; thus, drugs with minimal side effects would be desirable as additions to current therapies to combat the global TB epidemic. OHet72 i...

(This article belongs to the Special Issue Optimizing Aerosol Therapy: Strategies for Pulmonary Drug Delivery)
  • Review
  • Open Access
495 Views
31 Pages

Surface-Engineered Phytochemical Nanomedicines for Postmenopausal Osteoporosis: Skeletal Targeting, Imaging-Supported Evaluation, and Therapeutic Performance

  • Hongwei Gao,
  • Shaorong Li,
  • Han Wu,
  • Weijian Wang and ,
  • Jianshi Song,
  • Jiaqi Li,
  • Xiuqi Shan and
  • Wei Zhang
  • + 3 authors+ 0 author

Postmenopausal osteoporosis (PMOP) is a metabolic bone disease driven by estrogen deficiency and a major contributor to fragility fractures, yet long-term use of current antiresorptive and anabolic agents remains constrained by tolerability and adher...

(This article belongs to the Special Issue Surface-Engineered Nanomedicines for Imaging-Guided Delivery and Enhanced Therapeutic Performance)
  • Article
  • Open Access
476 Views
12 Pages

Population Pharmacokinetics of Subcutaneous Infliximab: A Real-World Study of Naïve and Switch Patients

  • Blanca Vicente,
  • Hinojal Zazo,
  • José Germán Sánchez-Hernández,
  • Natalia Revilla and
  • Paulo Teixeira-da-Silva

Background: Subcutaneous infliximab (SC-IFX) represents a significant advance for patients with inflammatory bowel disease (IBD) due to the possibility of home self-administration. However, at this time, there are no clear recommendations for impleme...

(This article belongs to the Special Issue Personalized Drug Therapy: The Role of Pharmacokinetics and Therapeutic Drug Monitoring, 2nd Edition)
  • Review
  • Open Access
678 Views
46 Pages

Biomaterials intended for wound healing are expected to reduce microbial load while supporting tissue repair in complex wound environments. Plant-mediated synthesis of silver nanoparticles (AgNPs) has attracted interest because plant extracts can pro...

(This article belongs to the Special Issue Advanced Nanomaterials and Drug Delivery Systems for Wound Healing and Antimicrobial Therapy)
  • Article
  • Open Access
5 Citations
492 Views
22 Pages

Background: Simultaneous controlled release of multiple therapeutics from a single dosage form is a major frontier in modern pharmaceutics and a key strategy for modernizing traditional Chinese medicine. Methods: Using finasteride (FIN) and a Jing-Zh...

(This article belongs to the Special Issue Application of Electrospinning Technology in Pharmaceutical Engineering)
  • Article
  • Open Access
605 Views
17 Pages

Octreotide-Mediated Co-Solubilization of Paclitaxel and Docetaxel: A Novel Targeted Formulation for Synergistic Anticancer Chemotherapy

  • Ahmed A. H. Abdellatif,
  • Hesham M. Tawfeek,
  • Mahmoud Zaki El-Readi,
  • Amani E. Alharbi and ,
  • Hamzah M. Maswadeh,
  • Mohammed A. Amin,
  • Safaa Y. Eid,
  • Abousree T. Ellethy,
  • Bassem Refaat and
  • Mahmoud A. Younis
  • + 7 authors+ 2 authors

Background: Herein, we report on the development of a novel submicron-sized formulation that utilizes the somatostatin receptor agonist, octreotide (OCT), for the solubilization and targeted delivery of paclitaxel (PTX) and docetaxel (DTX) to the can...

(This article belongs to the Section Drug Targeting and Design)
  • Article
  • Open Access
576 Views
17 Pages

Developing a Fluorescence-Based High-Throughput Screening Method for Natural Product Fractions to Identify Inhibitors of AR-V7 for Castration-Resistant Prostate Cancer

  • Neha Tyagi,
  • Manish Rathi,
  • Susan Ensel,
  • Christopher C. Thornburg and ,
  • Tanja Grkovic,
  • Barry R. O’Keefe,
  • James C. Sacchettini and
  • Chendil Damodaran
  • + 3 authors+ 0 author

Background/Objectives: The progression of prostate cancer to castration-resistant prostate cancer (CRPC) is often driven by constitutively active androgen receptor splice variants, such as AR-V7, which evade conventional androgen-deprivation therapie...

(This article belongs to the Special Issue Natural Bioactive Compounds for Targeted Cancer Therapy)
  • Article
  • Open Access
419 Views
19 Pages

Manganese Dioxide Nanoparticles Protect PC12 Cells Against H2O2-Induced Oxidative Stress Injury by Regulating PI3K/Akt-Mediated Autophagy

  • Weijian Zeng,
  • Duanyang Zhou,
  • Tianlong Wang,
  • Zhan-Lu Ma-Högemeier and ,
  • Song Cai,
  • Bingfeng Liu,
  • Chao Song,
  • Ling Guo,
  • Rihong Zhai and
  • Yun Dong
  • + 7 authors+ 2 authors

Background: Oxidative stress-mediated neuronal injury is critically involved in the pathogenesis of neurodegenerative disorders, including Alzheimer’s disease and Parkinson’s disease. Manganese dioxide (MnO2), owing to its intrinsic react...

(This article belongs to the Special Issue Advanced Drug Nanocrystals)
  • Review
  • Open Access
840 Views
36 Pages

Background: Artificial intelligence (AI) is transforming pharmacology and pharmacotherapy by enabling the integration of large, heterogeneous datasets to support precision and personalised medicine. However, the reliability of AI-assisted therapeutic...

(This article belongs to the Topic New Approaches to Machine Learning Parameters in Pharmacology and Pharmacotherapy for Drug Targeting and Precision Medicine)
  • Article
  • Open Access
523 Views
23 Pages

Reductant-Responsive Squalene Dual-Prodrug Nanoparticles Co-Delivering Doxorubicin and Exatecan for Synergistic Breast Tumor Therapy

  • Li Wang,
  • Ning Yang,
  • Yina Sa,
  • Zhenghua Li and ,
  • Yanlong Qiao,
  • Yanxin Yang,
  • Lixue Chen,
  • Xiangyu Liu and
  • Lei Li
  • + 4 authors+ 0 author

Background: combination chemotherapy employing agents with complementary mechanisms of action can enhance therapeutic efficacy and overcome resistance, but mismatched pharmacokinetics and systemic toxicity limit benefit. Methods: We designed reductan...

(This article belongs to the Section Nanomedicine and Nanotechnology)
  • Review
  • Open Access
593 Views
29 Pages

Background/Objectives: Busulfan is a cornerstone conditioning agent for pediatric hematopoietic stem cell transplantation (HSCT), yet its narrow therapeutic index and substantial pharmacokinetic (PK) variability complicate dosing. This review synthes...

(This article belongs to the Special Issue Model-Informed Precision Dosing in Drug Development and Clinical Practice)
  • Article
  • Open Access
951 Views
15 Pages

Leachable-Derived Impurities in Oral Solid Dosage Forms Generated by Solid-State Packaging–Excipient Interactions: A Case Study of a Polyvinyl Chloride Heat Stabilizer Reacting with Povidone

  • Ewoud Vaneeckhaute,
  • Julie Van Hooste,
  • Pasquinel Weckx,
  • Andrew Teasdale and ,
  • Ruud Cuyvers,
  • Jonathan Hammond,
  • Daniel Wood,
  • Ward D’Autry,
  • Laura Martin and
  • Eric Breynaert
  • + 5 authors+ 0 author

Background/Objectives: Oral solid dosage (OSD) forms are historically categorized as low-risk vectors for leachables under the assumption that solid-state matrices impose severe kinetic barriers against migrant migration and reactivity. This study in...

(This article belongs to the Section Physical Pharmacy and Formulation)
  • Review
  • Open Access
703 Views
54 Pages

Background: In vitro skin models are widely used in dermal and transdermal drug development, yet their pharmacokinetic interpretation often remains endpoint-dependent and does not fully capture cutaneous disposition, including partitioning, local met...

(This article belongs to the Special Issue Current and Future Perspectives in Dermal and Transdermal Drug Delivery)
  • Review
  • Open Access
1 Citations
935 Views
51 Pages

Biologically Mediated Nanoparticle Synthesis as a Potential Green Strategy: Principles, Methods, and Pharmaceutical Applications

  • Mahmoud M. Mokhtar,
  • Rahma Wael Soliman,
  • Jassy Salim,
  • Shrouk Khaled Mohamed and ,
  • Lobna Abdelsalam and
  • Rehab Abdelmonem
  • + 1 author+ 0 author

Nanoparticles have gained considerable attention as important platforms in pharmaceutical and biomedical research due to their size, morphology, surface chemistry, and colloidal behavior, which can affect drug delivery, antimicrobial activity, diagno...

(This article belongs to the Section Nanomedicine and Nanotechnology)
  • Article
  • Open Access
1 Citations
507 Views
19 Pages

PSMA-Targeted Liposomes for Therapeutic Delivery into a Prostate Cancer Cell Model

  • Miguel Ferreira,
  • Neelum Aziz Yousafzai,
  • Lital Ben Naim,
  • Bahar Ataeinia and ,
  • Umar Mahmood and
  • Pedram Heidari
  • + 1 author+ 0 author

Background: Prostate cancer (PCa) remains a significant health challenge, requiring innovative treatments. Here, we evaluated the efficacy of Talazoparib-loaded liposomes incorporating a targeting moiety, in combination with BI 2536, in PCa. This stu...

(This article belongs to the Special Issue Radiopharmaceutical Therapy: Latest Advances and Prospects)
  • Article
  • Open Access
616 Views
15 Pages

Introduction: The use of Δ8-tetrahydrocannabinol (Δ8-THC) has become increasingly prevalent in the United States, but its metabolic pathways remain poorly characterized. This study aimed to identify the key enzymes responsible for the 11&...

(This article belongs to the Section Pharmacokinetics and Pharmacodynamics)
  • Review
  • Open Access
1 Citations
1,289 Views
40 Pages

Plant-derived bioactives offer diverse pharmacological activities, but their development is often limited by poor aqueous solubility, instability, rapid metabolism, and low tissue exposure. This review examines delivery platforms used to address thes...

(This article belongs to the Special Issue Drug Delivery for Natural Extract Applications)
  • Article
  • Open Access
603 Views
19 Pages

Connecting the Dots Between Pharmacokinetics, Inflammatory Biomarkers, and Mucosal Healing in Patients on Infliximab with Inflammatory Bowel Disease

  • Ana Homšek Ilić,
  • Marija Jovanović,
  • Srđan Marković,
  • Sandra Vezmar Kovačević and ,
  • Tamara Knežević Ivanovski,
  • Petar Svorcan,
  • Radojka Savić and
  • Katarina Vučićević
  • + 3 authors+ 0 author

Background/Objectives: Mucosal healing (MH) is a key therapeutic target in inflammatory bowel disease (IBD) associated with sustained remission, reduced hospitalisation, and improved outcomes. Its assessment relies on endoscopic evaluation, which is...

(This article belongs to the Special Issue Optimizing Drug Therapy Through Pharmacokinetics and Therapeutic Drug Monitoring)
  • Article
  • Open Access
744 Views
15 Pages

CHILD-IVITAB, a Novel Orodispersible Ivermectin Formulation—Pharmaceutical Evaluation and Clinical Acceptability in Children <15 kg

  • Diell Aliu,
  • Thibault Vallet,
  • Jörg Huwyler,
  • Maxim Puchkov and ,
  • Lorenna Pereira de Souza,
  • Eline Freitas Medeiros,
  • Wuelton Monteiro,
  • Jacqueline de Almeida Gonçalves Sachett,
  • Fabrice Ruiz and
  • Kevin C. Kobylinski
  • + 9 authors+ 4 authors

Background/Objectives: Scabies is a disease that disproportionately affects young children. Oral ivermectin is a mainstay of scabies therapy, yet children <15 kg are excluded due to insufficient safety data and the lack of age-appropriate formulat...

(This article belongs to the Section Physical Pharmacy and Formulation)

of 4

XFacebookLinkedIn
Pharmaceutics - ISSN 1999-4923